Special audit report on the summary table of non-operating fund occupation and other related fund transactions of Jidan Biotechnology Co., Ltd.
Regarding the occupation of non-operating funds and other related fund transactions of Jidan Biotechnology Co., Ltd.
Special audit report for summary table
Directory
Special audit report
Schedule
Entrusting unit: Jidan Biotechnology Co., Ltd.
Audit unit: Gongzheng Tianye Accounting Firm (Special General Partnership)
Contact number: 025-68568577
Schedule 2
About Jidan Biotechnology Co., Ltd.
Table of non-operating fund occupation and other related fund transactions in 2025
Unit: 10,000 yuan in 2025
2025 2025
Occupier and listed listed company Accumulated occupation repayment in 2025 2025 period
Non-operating funds accounted for. Fund occupier. Opening account. Appropriation of funds. Appropriation form.
The company's related parties account for the amount that will occur and the accumulated amount of unoccupied capital. The nature of the occupation is used. The name of the capital is the reason for the interest.
Department accounting account (excluding interest amount and balance
Balance (if any)
information)
Non-operating current controlling shareholder, actual
Occupying the actual controller and its affiliates
Non-commercial enterprise
Occupation subtotal // / / /Non-operating former controlling shareholder, actual
Occupying the actual controller and its affiliates
Non-commercial enterprise
Subtotal of occupation / / / / /Other non-operating related parties and their occupied subsidiaries Subtotal of non-operating occupation / / / / /Total / / / / /
2025
2025 2025
Listed company Accumulated transactions Repayment in 2025 2025
Other related capital transactions. Capital correspondent. Correspondent and listed. Opening transaction. Degree of transaction. Transaction form.
The calculated transaction amount, the accumulated amount of current transactions, the nature of the transaction, the name of the company, the relationship between the current funds, the interest on the funds, and the reason for the occurrence
Accounting items (excluding interest amount and balance)
Balance (if any)
information)
controlling shareholder, actual
Controller and its affiliates
enterprise
Hubei Jidan Medical Subsidiaries and their controlling interests Non-operating
Other receivables 2,232.16 7.19 43.50 2,282.85 - Current accounts
Equipment Co., Ltd. is a legal person with equity interests in Nanjing Jidan
Subsidiaries and their controlled non-operating investment management Co., Ltd. Other receivables 0.04 0.74 - 0.78 - Current accounts
legal person, counterparty company
Jiangsu Jidan Biotechnology Subsidiaries and their controlling interests Non-operating
Other receivables - 2,654.00 - 1,096.71 1,557.29 Current accounts
Pharmaceutical Co., Ltd., a legal person operating between Xinjiang Pomegranate Seed Medical
Subsidiaries of listed companies and their controlled non-operating sexual therapy equipment Co., Ltd. Other receivables 3,409.29 12.08 57.64 2,501.97 977.04 Current accounts
The company and its affiliated enterprises are legal persons. Correspondence Department
Shun Wei (Shandong) physician
Subsidiaries and their controlled non-operating Science Technology Co., Ltd. Other receivables 265.18 250.00 16.04 28.73 502.50 Current accounts
Legal Person Correspondence Department
Xinjiang Jidan Medical Subsidiaries and their controlling interests Non-operating
Other receivables 206.42 95.50 - - 301.92 Current accounts
Equipment Co., Ltd. is a legal person with Jiangsu Kerui Precision subsidiaries and its controlling interests. Non-operating
Other receivables 128.60 - - 128.60 - Current accounts
Technology Co., Ltd., a legal person
Related natural person
Jiangsu Hanya Medical actually controls ginseng rent and business transactions
Accounts receivable - 125.89 - 125.50 0.38
Other related parties and their subsidiaries of Water and Power Technology Co., Ltd. Jiangsu Hanya Medical actually control ginseng, advance delivery, operating transactions
Prepayment 0.06 - - 0.06 -
Technology Co., Ltd., a company with shares, came to Nanjing Hanya Health to actually control the ginseng sales instrument for business purposes.
Accounts receivable - 26.00 - 13.00 13.00
Technology Co., Ltd. Shares of Enterprise Devices Come
sales test
Anhui Jiyun Biotech once controlled holdings with operating interests
Accounts receivable 76.20 568.15 - 644.35 - Agents and Instruments
Technology Co., Ltd. Subsidiary Laiji
sales test
Huangshi Xingmiao Technology once controlled the holding business transaction
Accounts receivable - 221.82 - 21.95 199.87 Agents and Instruments
Ltd. Subsidiary Come
device
Jizhongkang (Hangzhou Sales Trial
Previously controlled holdings (operating state) biomedical accounts receivable - 245.84 - 67.46 178.38 Agents and instruments
Subsidiaries to Co., Ltd.
Xinjiang Huayu Taixiang
Holdings once controlled Non-operating Biotechnology Co., Ltd. Other receivables 155.83 - - 155.83 - Dividends
Subsidiaries Corresponding companies
Wuhan Jingchuan Diagnostics
Prepaid goods Operating to the holding subsidiary of Technology Co., Ltd. Prepayments 5.17 - - - 5.17
Come to the company
sales test
Wuhan Jingchen Biotech Business Development
Accounts receivable of holding subsidiaries - 8.04 8.04 - JJJI
Technology Co., Ltd. - Come
device
Total / / / 6,478.95 4,215.25 117.18 7,075.83 3,735.55 / /Note 1: Xinjiang Huayu Taixiang Biotechnology Co., Ltd., Anhui Jiyun Biotechnology Co., Ltd., Huangshi Xingmiao Technology Co., Ltd., and Jizhongkang (Hangzhou) Biomedical Co., Ltd. were holding subsidiaries controlled by the company. They were no longer included in the consolidated financial statements due to the external transfer of all equity in January 2023, October 2024, February 2025, and November 2025 respectively. Wuhan Jingchuan Diagnostic Technology Co., Ltd. and its subsidiaries will no longer be included in the scope of consolidated statements from July 1, 2024. Taking into account the continuity of information disclosure, the transactions will be disclosed under "Other related parties and their affiliated enterprises". Note 2: If there is a discrepancy between the total and the sum of each sub-item in the above table, it is due to rounding.